Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer

por Papadaki, Chara, Stratigos, Michalis, Markakis, Georgios, Spiliotaki, Maria, Mastrostamatis, Georgios, Nikolaou, Christoforos, Mavroudis, Dimitrios, Agelaki, Sofia
Publicado 2018

Correction to: Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer

por Papadaki, Chara, Stratigos, Michalis, Markakis, Georgios, Spiliotaki, Maria, Mastrostamatis, Georgios, Nikolaou, Christoforos, Mavroudis, Dimitrios, Agelaki, Sofia
Publicado 2022

Dynamic monitoring of PD‐L1 and Ki67 in circulating tumor cells of metastatic non‐small cell lung cancer patients treated with pembrolizumab

por Spiliotaki, Maria, Neophytou, Christiana Michael, Vogazianos, Paris, Stylianou, Ioannis, Gregoriou, Gregoria, Constantinou, Andreas Ioannou, Deltas, Constantinos, Charalambous, Haris
Publicado 2022

Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy

por Spiliotaki, Maria, Mavroudis, Dimitris, Kapranou, Kyriaki, Markomanolaki, Harris, Kallergi, Galatea, Koinis, Filippos, Kalbakis, Kostas, Georgoulias, Vassilis, Agelaki, Sofia
Publicado 2014

Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes

por Spiliotaki, Maria, Mavroudis, Dimitris, Kokotsaki, Maria, Vetsika, Eleni‐Kyriaki, Stoupis, Ioannis, Matikas, Alexios, Kallergi, Galatea, Georgoulias, Vassilis, Agelaki, Sofia
Publicado 2017